Search Results 821-830 of 11394 for anti-TNF drugs
The purpose of this study is to measure the treatment response from Efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory ...
Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease. Crohn's & ...
A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...
... anti-cancer treatment and have a positive 68Ga-PSMA-11 PET scan. The purpose of this study is to learn if the study drug, [225Ac]Ac-PSMA-R2, is safe and ...
In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in the ...
Combining the drugs with CAR-T cell therapy resulted in better tumor control and survival in preclinical models than either approach alone. Rather than ...
By condition, treatment or drug ... A Phase 1 Dose Escalation And Cohort Expansion Study Of TSR-042, An Anti-PD-1 Monoclonal Antibody, In Patients With Advanced ...
Participation eligibility · Use of systemic chronic steroid therapy (≥10mg /day of prednisone or equivalent), or any immunosuppressive therapy within 7 days of ...
... medicines. You receive these through a needle in a vein at the hospital. Anti-parasitics. Some diseases, including malaria, are caused by tiny parasites ...
... drugs were tested," Dr. Daniels says. "These drugs can kill tumors in a petri dish. The challenge is getting a drug to the tumor in patients and making sure ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.